CRISPR THERAPEUTICS AG (CRSP)       63.1  -2.25 (-3.44%)

63.1  -2.25 (-3.44%)

CH0334081137 - Common Stock - After market: 62.44 -0.66 (-1.05%)

Buy % Consensus

Analysts have set a mean price target of 114.66. This target is 81.71% above the current price.
CRSP was analyzed by 32 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CRSP.
In the previous month the buy percentage consensus was at a similar level.
CRSP was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 63.1050.50105.57114.66231.00 - -19.97% 67.31% 81.71% 266.09%

Up and Down Grades

Date Firm Action Rating
2022-08-09 Chardan Capital Maintains Buy
2022-08-09 RBC Capital Maintains Sector Perform
2022-08-09 Barclays Downgrade Overweight -> Equal-Weight
2022-08-09 Credit Suisse Maintains Neutral
2022-08-08 SVB Leerink Maintains Outperform
2022-08-02 Citigroup Maintains Neutral
2022-06-23 Oppenheimer Maintains Outperform
2022-06-23 Evercore ISI Group Downgrade Outperform -> In-Line
2022-06-22 Chardan Capital Maintains Buy
2022-06-22 Stifel Maintains Hold
2022-06-22 Piper Sandler Maintains Overweight
2022-06-17 BMO Capital Initiate Outperform
2022-06-13 Stifel Maintains Hold
2022-05-24 Goldman Sachs Maintains Neutral
2022-05-23 Piper Sandler Maintains Overweight
2022-05-17 Citigroup Maintains Neutral
2022-05-13 Needham Maintains Buy
2022-05-11 JMP Securities Maintains Market Outperform
2022-05-11 Oppenheimer Maintains Outperform
2022-05-11 Goldman Sachs Maintains Neutral
2022-05-10 Chardan Capital Maintains Buy
2022-05-10 RBC Capital Maintains Sector Perform
2022-05-10 SVB Leerink Maintains Outperform
2022-05-10 Barclays Maintains Overweight
2022-04-28 Credit Suisse Initiate Neutral
2022-02-16 RBC Capital Maintains Sector Perform
2022-02-16 SVB Leerink Maintains Outperform
2021-12-07 Cowen & Co. Initiate Market Perform
2021-11-04 Barclays Maintains Overweight
2021-10-19 SVB Leerink Initiate Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA